Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Comparison Table: Semax vs Related Nootropic Peptides

Semax (Amidated) BDNF upregulation, dopamine/serotonin modulation, inhibition of enkephalin degradation 60–90 minutes Cognitive enhancement, neuroprotection in ischemic injury, ADHD symptom modulation Moderate (7 amino acids, standard SPPS) Gold standard for A

This comparison does not assign a generated winner or score.

  • Semax (Amidated)
  • BDNF upregulation, dopamine/serotonin modulation, inhibition of enkephalin degradation
  • 60–90 minutes
  • Cognitive enhancement, neuroprotection in ischemic injury, ADHD symptom modulation
  • Moderate (7 amino acids, standard SPPS)
  • Gold standard for ACTH-derived nootropics. Well-characterised mechanism, reproducible synthesis, extensive Russian clinical data
  • Selank
  • Anxiolytic via GABAergic modulation, IL-6 suppression, tuftsin analogue
  • 20–30 minutes (non-amidated degrades faster)
  • Anxiety reduction, immune modulation, stress resilience
  • Moderate (6 amino acids)
  • Complementary to Semax but distinct. Targets anxiety/stress pathways rather than cognitive performance directly
  • P21 (CNTF Fragment)
  • CNTF receptor activation, neurogenesis in hippocampus
  • Unknown (limited pharmacokinetic data)
  • Memory consolidation, neuroplasticity enhancement
  • High (derived from ciliary neurotrophic factor structure)
  • Emerging research compound. Mechanism promising but less characterised than Semax; our P21 formulation follows strict synthesis protocols
  • Cerebrolysin
  • Multi-peptide mixture (neurotrophic factors from porcine brain)
  • Variable (contains multiple active components)
  • Post-stroke recovery, traumatic brain injury, dementia
  • N/A (biological extraction, not synthetic)
  • Established clinical use in Europe/Asia but compositional variability limits reproducibility. Different mechanism class than synthetic peptides like Semax
  • Dihexa
  • Hepatocyte growth factor (HGF) mimetic, potent synaptogenesis inducer
  • 2–4 hours (estimated, limited human data)
  • Alzheimer's research, cognitive decline models
  • High (requires multi-step organic synthesis)
  • Extremely potent (7 orders of magnitude more active than BDNF in some assays) but human safety data minimal. Our Dihexa is research-grade only
More references

Related material